Prognostic relevance of immunohistochemical expression of Sox2, YAP1, and IMP3 in non-muscle invasive bladder cancer | ||||
Zagazig University Medical Journal | ||||
Article 28, Volume 28, Issue 6, November 2022, Page 1414-1429 PDF (1.51 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/zumj.2022.133357.2555 | ||||
View on SCiNiTO | ||||
Authors | ||||
Hanaa Mohamed Ibrahim1; Aziza E. Abdelrahman 2; Amira Elwan3; Eman Ali Elsebai 4; Ahmed Eliwa 5; Samah S. Elbasateeny6 | ||||
1Pathology faculty of medicine Zagazig university | ||||
2Pathology department, faculty of medicine, zagazig university, Egypt | ||||
3clinical oncology, faculty of medicine | ||||
4Clinical oncology department | ||||
5Urology department , Zagazig University | ||||
6pathology department,faculty of medicine,zagazig university,Egypt | ||||
Abstract | ||||
BACKGROUND: Despite advances in intravesical therapy and surgery, up to 30% of NMIBC suffer progression to MIBC. OBJECTIVES: To identify the valuable prognostic biomarkers, we analyzed the immunohistochemical expression of Sox2, YAP1, and IMP3 in 60 cases of NMIBC who underwent TURBT with adjuvant intravesical bacillus-Calmette-Guerin (BCG). METHODS: The immunohistochemical expression was done on a sixty patients who complained from primary papillary superficial transitional cell carcinoma (TCC) of the urinary bladder (Stage Ta-T1).Their predicting role for recurrence, progression, progression-free survival (PFS), and recurrence-free survival (RFS) was assessed. RESULTS: High Sox2 expression was observed in 55% of NMIBC cases, and it was significantly associated with the tumor size, grade, and stage (p < /p> | ||||
Keywords | ||||
Sox2; YAP1; IMP3; Non-muscle-invasive bladder cancer; Prognostic markers | ||||
Statistics Article View: 431 PDF Download: 209 |
||||